COCP vs EXPE · rev $105.0K vs P/E 20, rev $7.74B
Cocrystal Pharma Inc (COCP) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
COCP currently screens at market cap $13.3M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the COCP and EXPE stock pages for the full models.
Not investment advice.